Atracurium besylate
Added to RFQ
For Research & Analytical Purposes. Not for Personal use.
Packaging & Handling
Indicative product packaging is shown for visual reference. Actual packaging may vary based on pack size, quantity, storage condition and shipping requirements.
Documentation Available
Detailed specifications, certificates, and supporting documents are available upon request.
Detailed specifications, certificates, and supporting documents are available upon request.
Storage: Refer MSDS for complete information.
Hazard: Refer MSDS for accurate information.
Atracurium besylate Product Information
Atracurium besylate is listed under API and is intended for analytical research, quality control and pharmaceutical reference standard applications. It is associated with Atracurium. The product is supplied by Clearsynth under CAT No. CS-O-00905.
Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight and product enquiry details.
Technical Data
Product Name
Atracurium besylate
CAS No.
64228-81-5
CAT No.
CS-O-00905
HSN Code
38229010
Country of Origin
Can be shipped from India, Canada and USA
Molecular Formula
C65H82N2O18S2
Molecular Weight
1243.49
Category
API Family
Storage Condition
Refer MSDS for complete information.
Hazard Compound
Refer MSDS for accurate information.
Description
Regulatory Description
Atracurium besylate is supplied with detailed characterization data compliant with regulatory guideline. Atracurium besylate can be used for analytical method development, method validation (AMV), Quality Control (QC) application for Abbreviated New Drug Application (ANDA), or during commercial production of Atracurium.
Overview
Atracurium besylate is a non-depolarizing neuromuscular blocking agent with short duration of action. Its lack of significant cardiovascular effects and its lack of dependence on good kidney function for elimination provide clinical advantage over alterna
Synonyms
Atracurium besylate
Application Notes
Atracurium besylate is a non-depolarizing neuromuscular blocking agent with short duration of action. Its lack of significant cardiovascular effects and its lack of dependence on good kidney function for elimination provide clinical advantage over alterna
Product Applications & Regulatory Search Terms
Useful product, supplier and regulatory search terms for this reference standard.